193 related articles for article (PubMed ID: 37864034)
1. Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.
Siljamäki E; Riihilä P; Suwal U; Nissinen L; Rappu P; Kallajoki M; Kähäri VM; Heino J
Oncogene; 2023 Dec; 42(49):3633-3647. PubMed ID: 37864034
[TBL] [Abstract][Full Text] [Related]
2. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma.
Siljamäki E; Rappu P; Riihilä P; Nissinen L; Kähäri VM; Heino J
Matrix Biol; 2020 May; 87():26-47. PubMed ID: 31655292
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
4. Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes.
Kelley MB; Geddes TJ; Ochiai M; Lampl NM; Kothmann WW; Fierstein SR; Kent V; DeCicco-Skinner K
PLoS One; 2022; 17(3):e0266017. PubMed ID: 35325006
[TBL] [Abstract][Full Text] [Related]
5. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase.
Johansson N; Ala-aho R; Uitto V; Grénman R; Fusenig NE; López-Otín C; Kähäri VM
J Cell Sci; 2000 Jan; 113 Pt 2():227-35. PubMed ID: 10633074
[TBL] [Abstract][Full Text] [Related]
6. Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.
Nagura M; Matsumura N; Baba T; Murakami R; Kharma B; Hamanishi J; Yamaguchi K; Abiko K; Koshiyama M; Mandai M; Murata T; Murphy SK; Konishi I
Gynecol Oncol; 2015 Jan; 136(1):104-11. PubMed ID: 25434636
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in keratinocyte carcinomas.
Riihilä P; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Jan; 30(1):50-61. PubMed ID: 32869366
[TBL] [Abstract][Full Text] [Related]
8. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
[TBL] [Abstract][Full Text] [Related]
10. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
Gao D; Chen HQ
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
[TBL] [Abstract][Full Text] [Related]
11. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
[TBL] [Abstract][Full Text] [Related]
12. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.
Quadri M; Tiso N; Musmeci F; Morasso MI; Brooks SR; Bonetti LR; Panini R; Lotti R; Marconi A; Pincelli C; Palazzo E
J Exp Clin Cancer Res; 2023 Jul; 42(1):167. PubMed ID: 37443031
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
14. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
16. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells.
Rahmati Nezhad P; Riihilä P; Piipponen M; Kallajoki M; Meri S; Nissinen L; Kähäri VM
Exp Dermatol; 2021 Nov; 30(11):1631-1641. PubMed ID: 33813765
[TBL] [Abstract][Full Text] [Related]
17. miR-506 contributes to malignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1.
Zhou J; Zhang Y; Han Z; Dong Z; Cao T; Wei A; Guo P; Meng Q
Cell Cycle; 2019 Feb; 18(3):333-345. PubMed ID: 30646812
[TBL] [Abstract][Full Text] [Related]
18. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
[TBL] [Abstract][Full Text] [Related]
19. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
Mannella V; Boehm K; Celik S; Ali T; Mirza AN; El Hasnaouy M; Kaffa A; Lyu Y; Kafaei Golahmadi D; Leigh IM; Bergamaschi D; Harwood CA; Maffucci T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808215
[TBL] [Abstract][Full Text] [Related]
20. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.
Hsu CY; Yanagi T; Maeda T; Nishihara H; Miyamoto K; Kitamura S; Tokuchi K; Ujiie H
Sci Rep; 2023 May; 13(1):8650. PubMed ID: 37244956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]